HengRui USA is a new entity solely owned by our parent company Jiangsu Hengrui Pharmaceuticals. The foundation of HengRui USA is rooted in our parent company Jiangsu Hengrui Pharmaceuticals’ strong pipeline and products across therapeutic areas such as oncology, metabolics, autoimmune, pain management, etc.
Our work here at HengRui USA focuses on the multiple stages of the drug development process, from both a clinical and regulatory perspective. HengRui USA operates as the U.S. hub for our parent company’s Drug Development network by providing local expertise and resources for both U.S. and global development initiatives of Jiangsu Hengrui Pharmaceuticals.
Mission: To sustain a healthy life for people worldwide through scientific research!
Vision: We strive to be the Center of Excellence on Drug Development that delivers HengRui’s innovative medicines to patient in the US and around the world.